BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30044597)

  • 1. Objective value on Apparent diffusion coefficient (ADC) map to categorize the intensity of diffusion-weighted imaging (DWI) restriction for prostate cancer detection on multiparametric prostate MRI.
    Mussi TC; Martins T; Tachibana A; Mousessian PN; Baroni RH
    Int Braz J Urol; 2018; 44(5):882-891. PubMed ID: 30044597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional vs. reduced field of view diffusion weighted imaging of the prostate: Comparison of image quality, correlation with histology, and inter-reader agreement.
    Warndahl BA; Borisch EA; Kawashima A; Riederer SJ; Froemming AT
    Magn Reson Imaging; 2018 Apr; 47():67-76. PubMed ID: 29103977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of Index Lesion Size and Mean Apparent Diffusion Coefficient Values Measured by Prostate Multiparametric MRI: Correlation With Whole-Mount Sectioning of Specimens.
    Diaz de Leon A; Leyendecker JR; Otero-Muinelo S; Grewal H; Xi Y; Francis F; Pedrosa I; Costa DN
    AJR Am J Roentgenol; 2018 Oct; 211(4):783-788. PubMed ID: 30160988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Dynamic Contrast-enhanced and Diffusion MRI to PI-RADS for Detecting Clinically Significant Prostate Cancer.
    Tavakoli AA; Hielscher T; Badura P; Görtz M; Kuder TA; Gnirs R; Schwab C; Hohenfellner M; Schlemmer HP; Bonekamp D
    Radiology; 2023 Jan; 306(1):186-199. PubMed ID: 35972360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences.
    Bura V; Caglic I; Snoj Z; Sushentsev N; Berghe AS; Priest AN; Barrett T
    Eur Radiol; 2021 Jul; 31(7):4908-4917. PubMed ID: 33398421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images.
    Abd-Alazeez M; Ramachandran N; Dikaios N; Ahmed HU; Emberton M; Kirkham A; Arya M; Taylor S; Halligan S; Punwani S
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):128-36. PubMed ID: 25644248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Objective Value of the Apparent Diffusion Coefficient (ADC) Map from Ultrahigh b-value Diffusion-weighted Imaging (DWI) in 3T MRI could be a Non-invasive Specific Biomarker for Prostate Cancer.
    Zhang K; Zhang C; Chen Z; Zhang Y; Dong Z; Hu Y; Wang M; Fu Y; Ye H; Shen Y
    Curr Med Imaging; 2023 Jul; ():. PubMed ID: 37464833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T.
    Rosenkrantz AB; Kim S; Campbell N; Gaing B; Deng FM; Taneja SS
    AJR Am J Roentgenol; 2015 Mar; 204(3):W266-72. PubMed ID: 25714311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).
    Gaur S; Harmon S; Gupta RT; Margolis DJ; Lay N; Mehralivand S; Merino MJ; Wood BJ; Pinto PA; Shih JH; Choyke PL; Turkbey B
    Acad Radiol; 2019 Jan; 26(1):5-14. PubMed ID: 29705281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Weighted Diffusion Subtraction for Detection of Clinically Significant Prostate Cancer.
    Sato T; Isoda H; Fujimoto K; Furuta A; Fujimoto M; Ito K; Kobayashi T; Nakamoto Y
    J Magn Reson Imaging; 2021 Dec; 54(6):1979-1988. PubMed ID: 34085328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.
    Rosenkrantz AB; Chandarana H; Gilet A; Deng FM; Babb JS; Melamed J; Taneja SS
    J Magn Reson Imaging; 2013 Aug; 38(2):312-9. PubMed ID: 23238968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of ADC ratio in discriminating true and false positives in multiparametric prostatic MRI.
    Falaschi Z; Valenti M; Lanzo G; Attanasio S; Valentini E; García Navarro LI; Aquilini F; Stecco A; Carriero A
    Eur J Radiol; 2020 Jul; 128():109024. PubMed ID: 32387923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measured Multipoint Ultra-High b-Value Diffusion MRI in the Assessment of MRI-Detected Prostate Lesions.
    Tavakoli AA; Kuder TA; Tichy D; Radtke JP; Görtz M; Schütz V; Stenzinger A; Hohenfellner M; Schlemmer HP; Bonekamp D
    Invest Radiol; 2021 Feb; 56(2):94-102. PubMed ID: 32930560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracapsular extension in prostate cancer: added value of diffusion-weighted MRI in patients with equivocal findings on T2-weighted imaging.
    Woo S; Cho JY; Kim SY; Kim SH
    AJR Am J Roentgenol; 2015 Feb; 204(2):W168-75. PubMed ID: 25615777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Apparent Diffusion Coefficient Values Assist PI-RADS Version 2 DWI Scoring? A Correlation Study Using the PI-RADSv2 and International Society of Urological Pathology Systems.
    Gaur S; Harmon S; Rosenblum L; Greer MD; Mehralivand S; Coskun M; Merino MJ; Wood BJ; Shih JH; Pinto PA; Choyke PL; Turkbey B
    AJR Am J Roentgenol; 2018 Jul; 211(1):W33-W41. PubMed ID: 29733695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Apparent Diffusion Coefficient Derived From Diffusion-Weighted Imaging Has the Potential to Avoid Unnecessary MRI-Guided Biopsies of mpMRI-Detected PI-RADS 4 and 5 Lesions.
    Polanec SH; Helbich TH; Bickel H; Wengert GJ; Pinker K; Spick C; Clauser P; Susani M; Shariat S; Baltzer PAT
    Invest Radiol; 2018 Dec; 53(12):736-741. PubMed ID: 29985792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which clinical and radiological characteristics can predict clinically significant prostate cancer in PI-RADS 3 lesions? A retrospective study in a high-volume academic center.
    Hermie I; Van Besien J; De Visschere P; Lumen N; Decaestecker K
    Eur J Radiol; 2019 May; 114():92-98. PubMed ID: 31005183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-to-high b value DWI ratio approaches in multiparametric MRI of the prostate: feasibility, optimal combination of b values, and comparison with ADC maps for the visual presentation of prostate cancer.
    Xi Y; Liu A; Olumba F; Lawson P; Costa DN; Yuan Q; Khatri G; Yokoo T; Pedrosa I; Lenkinski RE
    Quant Imaging Med Surg; 2018 Jul; 8(6):557-567. PubMed ID: 30140618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.